Contract sales market on the rise thanks to wider range of services from CSOs

Related tags Contract sales Bric Pharmacology

Contract sales market on the rise
The contract sales market is set to hit $3.9bn in 2013, according to visiongain.

The growth - up eight per cent year-on-year – is the result of a growing demand for the wider range of services now offered by contract sales organisations (CSOs).

Services offered in market access strategy and assisting patient compliance were all listed as new “sources of revenue”​ for the vendors.

Medical education services was listed as a particularly promising submarket. The analysts wrote “In 2011, medical education services accounted for only a small share of the contract sales market – with worldwide revenue totalling $161m.”

However the researchers say education services are among the “fastest growing sectors”,​ and that CSOs take up the largest chunk of contracts with pharma firms.

Richard Lang, pharmaceutical industry analyst for visiongain, said: "Pharmaceutical sales models are changing rapidly. Healthcare payers have greater influence in prescribing decisions, complicating market access strategies for pharmaceutical companies.

“CSOs are expanding beyond traditional sales services to meet demand for market access expertise from pharmaceutical partners.”

BRIC growth

The study showed that the US and Europe currently accounts for the largest section of the market, taking up over 75 per cent of it in 2011.

However, visiongain says Western firms' increasing presence in emerging countries will boost contract sales in those regions.

Lang added: “Market leaders, such as inVentiv Health, Quintiles and United Drug, already operate on a global scale. Recently these companies made advances into emerging markets, establishing offices in the BRIC nations (Brazil, Russia, India and China).

“Outsourcing will provide local expertise in market access and sales models. Fast growth is forecast for all four of the BRIC nations, in terms of contract sales, to 2023."

Related news

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Related suppliers

Follow us